← Back to SYRSPortrait, one to two pages. Turn on “background graphics” in the print dialog to keep the table rules.
SPZCOSyros Pharmaceuticals, Inc. · SYRSData at close 2025-03-20
· Prices AT CLOSE 2025-03-20 (USD) — end-of-day, never a live or intraday quote
Last$0.11 · 1Y−97.1% · Off 52W high−99.7% · Vol (1Y)5235.9%
Price2023-07-21 → 2026-07-21
SYRS close: $3.50 on 2023-07-21 to $0.00 on 2026-07-21.
Daily closing price, split-adjusted to the current basis; 2.9y shown of 2,496 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
At a glance
Days to cover2.9d
Short interest is FINRA semi-monthly, settlement 2026-07-15.
Key fundamentals
SYRS is not in the screener universe.
Trailing returns
YTD−66.7%
1Y−97.1%
3Y−100.0%
5Y−100.0%
10Y−100.0%
Since incept. (ann.)−75.9%
Total return through 2025-03-20 · series begins 2016-07-11. Only the windows this history actually covers are shown.
Risk
Ann. volatility (1Y)5235.9%
Ann. volatility (3Y)2939.8%
Sharpe (1Y)1.38
Sharpe (3Y)0.78
Max drawdown (1Y)−99.5%
Max drawdown (3Y)−100.0%
Beta (3Y vs SPY)2.23
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
Top institutional holders13F 2026-Q1
No 13F holders on file for SYRS.
Latest reported quarters
No reported quarters on file for SYRS.
Basis & disclosures
End-of-day only. Every price on this sheet is a stored CLOSE — the last one is 2025-03-20. Nothing here is live, intraday or delayed-real-time, and the sheet does not update after it is printed.
Nothing is imputed. A figure that is not in the underlying filing or feed renders as “—”. We never fill a gap with an estimate, a peer median or a carried-forward value.
Mixed as-of dates by design. Prices are at the last close; fundamentals are at the latest reported fiscal period; 13F ownership is at the latest filed quarter (45+ days in arrears); short interest is the latest FINRA settlement. Each block states its own basis above.
Not investment advice. Model fair values, reverse-DCF grades and confidence labels are the output of published, disclosed methods on public filings — they are analysis, not a recommendation, a price target or a solicitation.
Fundamentals and ownership derive from SEC EDGAR (and equivalent foreign registers); prices from a licensed end-of-day vendor, shown under a neutral source label. Full methodology at spzco.com/methodology.
